清肺扶正祛瘀法联合盐酸氨溴索注射液治疗支气管肺炎患者的疗效及对血沉、CRP水平影响

摘要/Abstract

摘要： 目的探讨清肺扶正祛瘀法联合盐酸氨溴索注射液治疗支气管肺炎患者的疗效及对血沉、C反应蛋白（CRP）水平影响。方法选取2018年6月—2022年6月烟台市蓬莱人民医院收治的80例支气管肺炎患者作为研究对象,应用随机数表法将所有患者分为观察组与对照组,每组40例。对照组采取盐酸氨溴索注射液治疗,观察组患者应用清肺扶正祛瘀法联合盐酸氨溴索注射液治疗,比较两组临床疗效以及治疗前后白细胞计数（WBC）、C反应蛋白（CRP）、血沉（ESR）表达情况,并比较两组患者肺啰音/哮鸣音消失时间、咳嗽消失时间、发热总天数、住院时间以及不良反应发生情况。结果观察组治疗总有效率明显高于对照组,差异有统计学意义（P<0.05）;治疗前两组患者WBC、ESR、CRP水平比较,差异无统计学意义（P>0.05）,治疗后两组患者WBC、ESR、CRP水平均降低,且观察组低于对照组,差异有统计学意义（P<0.05）;观察组患者肺啰音/哮鸣音消失时间、咳嗽消失时间、发热总天数、住院时间明显低短对照组,差异无统计学意义（P<0.05）;两组患者均无明显不良反应发生,差异无统计学意义（P>0.05）。结论清肺扶正祛瘀法联合盐酸氨溴索注射液治疗支气管肺炎疗效显著,能够进一步降低患者机体炎性反应,改善临床症状,促进患者早日康复,且安全性较高。

关键词: 清肺扶正祛瘀法, 盐酸氨溴索, 支气管肺炎, 血沉, C反应蛋白, 不良反应

Abstract: Objective To explore the efficacy of Qingfei Fuzheng Quyu method combined with ambroxol hydrochloride injection in the treatment of patients with bronchopneumonia and its influence on erythrocyte sedimentation rate and C-reactive protein (CRP) levels. Methods 80 bronchopneumonia patients admitted to Yantai Penglai People's Hospital from June 2018 to June 2022 were selected, and all patients were divided into observation group and control group by random number table method, with 40 cases in each group. The control group was treated with ambroxol hydrochloride injection, and the patients in the observation group were treated with clear lung fuzheng and removing stasis method combined with ambroxol hydrochloride injection. The clinical efficacy, white blood cell count (WBC), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) expression before and after treatment were compared, and the disappearance time of lung rale/wheezing and cough were compared between the two groups Total days of fever, hospital stay and adverse reactions. Results The total effective rate of the observation group was significantly higher than that of the control group (P<0.05); There was no significant difference in the levels of WBC, ESR and CRP between the two groups before treatment (P>0.05). After treatment, the levels of WBC, ESR and CRP in the two groups decreased, and the observation group was lower than the control group (P<0.05); The disappearance time of lung rale/wheezing, cough, total days of fever and hospital stay in the observation group were significantly lower than those in the control group (P<0.05); There were no significant adverse reactions in the two groups, and there was no significant difference in the adverse reactions (P>0.05). Conclusion The method of Qingfei Fuzheng Quyu and ambroxol hydrochloride injection has significant effect in the treatment of bronchopneumonia pneumonia, which can further reduce the inflammatory reaction of the patient, reduce the clinical symptoms as soon as possible, and promote the early recovery of the patient, with high safety and no obvious adverse reactions.

Key words: Qingfei Fuzheng Quyu method, ambroxol hydrochloride, bronchial pneumonia, erythrocyte sedimentation rate, C-reactive protein, adverse reactions

中图分类号:

R259

季永刚, 颜景辉. 清肺扶正祛瘀法联合盐酸氨溴索注射液治疗支气管肺炎患者的疗效及对血沉、CRP水平影响[J]. 中华养生保健, 2024, 42(4): 22-25.

JI Yong-gang, YAN Jing-hui. The Curative Effect of Qingfei Fuzheng Quyu Method Combined with Ambroxol Hydrochloride Injection on Patients with Bronchopneumonia and Its Influence on Erythrocyte Sedimentation Rate and CRP Level[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(4): 22-25.

参考文献

[1] 顾婷婷,尚莉丽.基于血清抗体检测分析2017-2019年合肥地区支气管肺炎患者肺炎支原体感染的单中心流行病学特征[J].新乡医学院学报,2021,38(9):839-841.
[2] 李伟,刘琳研,李娇,等.呼吸道合胞病毒感染致支气管肺炎患者继发血小板增多症的临床特征及意义[J].重庆医学,2020,49(19):3216-3219.
[3] 唐今尧,唐光钰.清肺祛瘀汤联合信必可都保治疗对支气管哮喘患者血清IgE,肺功能的影响[J].中国现代医学杂志,2021,31(3):19-23.
[4] 胡亚美,江载芳.诸福棠实用儿科学(第7版)(上下)(精)[M].北京:人民卫生出版社,2012:5-8.
[5] 刘瀚旻,马融.儿童肺炎支原体肺炎中西医结合诊治专家共识(2017年制定)[J].中国实用儿科杂志,2017,32(12):881-885.
[6] 刘传珍,周丽华.清肺扶正祛瘀法治疗小儿病毒性肺炎的临床报道[J].中华中医药杂志,1993,8(4):32-34.
[7] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:3-6.
[8] 马超颖,任明星,薛国昌,等.支气管镜肺泡灌洗氨溴索结合参芪扶正注射液治疗小儿重症支气管肺炎的效果观察[J].实用临床医药杂志,2021,25(23):37-40.
[9] 张翔,颜鹏飞,张宇,等.祛痰散热汤联合经皮理疗治疗小儿支气管肺炎临床疗效及对炎症因子水平的影响[J].四川中医,2020,38(8):86-89.
[10] 刘彩琴,胡荣全.盐酸氨溴索注射液治疗儿科呼吸系统疾病的疗效[J].中国妇幼保健,2021,36(7):1567-1569.
[11] 成鹏,黄帅,杨宇,等.网络药理学挖掘丹参-苦参药对提取物的抗炎药效及分子机制研究[J].中国药理学通报,2021,37(2):270-276.
[12] 邓博文,李筱叶,蒋昇源,等.黄芪桂枝五物汤对颈椎病和焦虑症”异病同治”作用机制的网络药理学分析[J].中国组织工程研究,2022,26(23):3650-3656.
[13] 李毓赟,李阳,王瑞杰,等.口服中成药治疗儿童支气管肺炎的网状Meta分析[J].中草药,2022,53(1):176-195.
[14] 宋威,万健,白金霞,等.HMGB1/TLR4通路在患反复支气管肺炎的老年患者治疗中的作用[J].临床和实验医学杂志,2022,21(7):712-715.
[15] 崔洪涛,刘芳,苗静琨,等.儿童支气管肺炎78490例出生-发病关联中医运气学研究[J].中华中医药杂志,2022,37(8):4797-4801.